Christopher J. Morl

Overview

Christopher J. Morl received an average of $987K in total compensation, including $204K in salary, at Deciphera Pharmaceuticals between 2016 and 2017.

Source: SEC filing on April 3, 2018.

Related executives

We found six more executives who work or worked at Deciphera Pharmaceuticals.

Steven Hoerter

Deciphera Pharmaceuticals

Chief Executive Officer

Matthew Sherman

Deciphera Pharmaceuticals

Chief Medical Officer

Daniel Flynn

Deciphera Pharmaceuticals

Chief Scientific Officer

Thomas Kelly

Deciphera Pharmaceuticals

Chief Financial Officer

Daniel Martin

Deciphera Pharmaceuticals

Chief Commercial Officer

Michael Taylor

Deciphera Pharmaceuticals

Chief Executive Officer

You may also like